<DOC>
	<DOCNO>NCT02609074</DOCNO>
	<brief_summary>Objective : The investigator initiate pilot clinical study test safety preliminary efficacy human ( bone tissue repair capacity ) evaluate standard clinical rehabilitation protocol . Summary Background Data : Bone tissue engineering scaffold load growth factor consider perspective among bone substitute , yet little progress clinical translation make . The concept `` micro-scaffolds '' propose study provide trajectory clinical translation . Methods : Pre-cured CPC/rhBMP-2 micro-scaffolds successfully develop apply easy-to-operate filler bone regeneration pilot clinical study . Patients tibial plateau fracture , proximal humeral fracture , calcaneal fracture similar level severity randomly divide two group treat CPC/rhBMP-2 microffolds traditional CPC paste ( control group ) .</brief_summary>
	<brief_title>Pilot Clinical Trial CPC/rhBMP-2 Microffolds Bone Substitute Bone Regeneration</brief_title>
	<detailed_description>Objective : The investigator initiate pilot clinical study test safety preliminary efficacy human ( bone tissue repair capacity ) evaluate standard clinical rehabilitation protocol . Summary Background Data : Bone tissue engineering scaffold load growth factor consider perspective among bone substitute , yet little progress clinical translation make . The concept `` micro-scaffolds '' propose study provide trajectory clinical translation . Methods : Pre-cured CPC/rhBMP-2 micro-scaffolds successfully develop apply easy-to-operate filler bone regeneration pilot clinical study . Patients tibial plateau fracture , proximal humeral fracture , calcaneal fracture similar level severity randomly divide two group treat CPC/rhBMP-2 microffolds traditional CPC paste ( control group ) .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<criteria>1 . Age 16~70 year . 2 . Tibial plateau fracture , proximal humeral fracture , calcaneal fracture similar level severity . 3 . An understanding rehabilitation protocol willing follow . 4 . An agreement postoperative visit test . 5 . Signed informed subject consent form .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>bone substitute</keyword>
	<keyword>CPC</keyword>
	<keyword>rhBMP-2</keyword>
</DOC>